These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 9238329)

  • 1. Photographic documentation of hair growth in androgenetic alopecia.
    Canfield D
    Dermatol Clin; 1996 Oct; 14(4):713-21. PubMed ID: 9238329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Female patients complaining about hair loss: documentation of defective scalp hair dynamics with contrast-enhanced phototrichogram.
    Van Neste D
    Skin Res Technol; 2006 May; 12(2):83-8. PubMed ID: 16626380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.
    Gubelin Harcha W; Barboza Martínez J; Tsai TF; Katsuoka K; Kawashima M; Tsuboi R; Barnes A; Ferron-Brady G; Chetty D
    J Am Acad Dermatol; 2014 Mar; 70(3):489-498.e3. PubMed ID: 24411083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of topical minoxidil therapy for androgenetic alopecia in women.
    Jacobs JP; Szpunar CA; Warner ML
    Int J Dermatol; 1993 Oct; 32(10):758-62. PubMed ID: 8225725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phototrichogram analysis of Japanese female subjects with chronic diffuse hair loss.
    Ueki R; Tsuboi R; Inaba Y; Ogawa H
    J Investig Dermatol Symp Proc; 2003 Jun; 8(1):116-20. PubMed ID: 12895007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phototrichogram.
    Dhurat R
    Indian J Dermatol Venereol Leprol; 2006; 72(3):242-4. PubMed ID: 16766847
    [No Abstract]   [Full Text] [Related]  

  • 7. Methods of evaluating hair growth.
    Chamberlain AJ; Dawber RP
    Australas J Dermatol; 2003 Feb; 44(1):10-8. PubMed ID: 12581076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical aspects of androgenetic alopecia].
    Le Clech C
    Ann Dermatol Venereol; 2000 Jun; 127 Suppl 1():1S10-2. PubMed ID: 10962362
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic telogen effluvium: potential complication for clinical trials in female androgenetic alopecia?
    Rand S
    J Am Acad Dermatol; 1997 Dec; 37(6):1021. PubMed ID: 9418786
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
    Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why care about linear hair growth rates (LHGR)? a study using in vivo imaging and computer assisted image analysis after manual processing (CAIAMP) in unaffected male controls and men with male pattern hair loss (MPHL).
    Van Neste D
    Eur J Dermatol; 2014; 24(5):568-76. PubMed ID: 25445091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hair cycle and alopecia.
    Courtois M; Loussouarn G; Hourseau C; Grollier JF
    Skin Pharmacol; 1994; 7(1-2):84-9. PubMed ID: 8003330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new technique for quantitative analysis of hair loss in mice using grayscale analysis.
    Ponnapakkam T; Katikaneni R; Gulati R; Gensure R
    J Vis Exp; 2015 Mar; (97):. PubMed ID: 25867252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of phototrichogram education on satisfaction of patients with androgenetic alopecia in clinical practice.
    Park SY; Lee WS
    J Dermatol; 2014 Aug; 41(8):773-4. PubMed ID: 24986264
    [No Abstract]   [Full Text] [Related]  

  • 15. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study.
    Shanshanwal SJ; Dhurat RS
    Indian J Dermatol Venereol Leprol; 2017; 83(1):47-54. PubMed ID: 27549867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Photographic documentation of the effectiveness of 1 mg. oral finasteride in treatment of androgenic alopecia in the man in routine general practice in Switzerland].
    Trüeb RM; Itin P;
    Praxis (Bern 1994); 2001 Nov; 90(48):2087-93. PubMed ID: 11770252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of hair loss in men with androgenetic alopecia (male pattern hair loss): long-term (5-year) controlled observational data in placebo-treated patients.
    Kaufman KD; Girman CJ; Round EM; Johnson-Levonas AO; Shah AK; Rotonda J
    Eur J Dermatol; 2008; 18(4):407-11. PubMed ID: 18573713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional methods for diagnosing alopecia and appraising their severity.
    Guarrera M
    G Ital Dermatol Venereol; 2014 Feb; 149(1):93-102. PubMed ID: 24566569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of hair loss: clinical relevance of hair growth evaluation methods.
    Van Neste MD
    Clin Exp Dermatol; 2002 Jul; 27(5):358-65. PubMed ID: 12190635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
    Gassmueller J; Hoffmann R; Webster A
    Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.